Allosteric Enzyme
An allosteric enzyme is a type of enzyme that has an additional specific binding site called an allosteric site, which is distinct from the active site where the substrate binds. The binding of molecules (called effectors or modulators) to the allosteric site induces a conformational change in the enzyme's structure, which can either enhance or inhibit its catalytic activity.
Mechanism of Allosteric Enzymes
Allosteric enzymes have two important sites:
- The active site, where the substrate binds.
- The allosteric site, where regulatory molecules called effectors bind.
When an effector binds to the allosteric site, it changes the enzyme's shape (conformation), which in turn alters how well the enzyme can bind to its substrate at the active site. This conformational change can either increase the enzyme's activity (activation) or decrease it (inhibition), allowing precise control over enzyme function.
Two main models explain this mechanism:
Concerted (Symmetry) Model: The enzyme exists in either an active (R) or inactive (T) form, and all parts of the enzyme switch states together. Substrate and activators promote the active form, whereas inhibitors stabilize the inactive form.
Sequential Model: Binding of a substrate to one unit changes only that unit's shape, which then influences neighboring units gradually to change their shape too.
Examples of Allosteric Enzymes
Aspartate Transcarbamoylase (ATCase): Important in nucleotide synthesis, regulated by nucleotides as effectors.
Phosphofructokinase (PFK): A key enzyme in glycolysis regulated by ATP and other molecules.
Hemoglobin (while not an enzyme, it behaves allosterically for oxygen binding).
Properties of Allosteric Enzymes
- They have multiple subunits (quaternary structure) with more than one binding site.
- Exhibit cooperative binding: binding of substrate to one site increases the likelihood of substrate binding to other sites.
- Show a sigmoidal (S-shaped) curve when their reaction rate is plotted against substrate concentration, unlike normal enzymes which have a hyperbolic curve.
- They respond to both inhibitory and stimulatory effectors at allosteric sites.
- They are usually involved in regulating metabolic pathways and act as rate-controlling steps.
Kinetics of Allosteric Enzymes
Allosteric enzymes do not follow classical Michaelis-Menten kinetics. Instead, their behavior is characterized by cooperativity, where the binding of a ligand to one subunit influences the binding properties of subsequent subunits.
1. Sigmoidal Velocity Curve
While standard enzymes produce a hyperbolic curve, allosteric enzymes yield a sigmoidal (S-shaped) curve when plotting reaction velocity ($v$) against substrate concentration ($[S]$). This reflects a transition from a low-affinity T-state (Tense) to a high-affinity R-state (Relaxed) as substrate concentration increases.
2. The Hill Equation and $n$
To quantify the degree of cooperativity, biochemists use the Hill Equation rather than the standard Michaelis-Menten equation:
$$v = \frac{V_{max} [S]^n}{K_{0.5}^n + [S]^n}$$
- $K_{0.5}$: The substrate concentration at which half-maximal velocity is reached (replacing $K_m$).
- $n$ (Hill Coefficient): A measure of cooperativity. If $n > 1$, the enzyme exhibits positive cooperativity; the higher the $n$, the steeper the "S" curve.
3. Modulation by Effectors
Allosteric effectors alter the enzyme's kinetic profile by shifting the equilibrium between the T and R states:
| Effector Type | State Stabilized | Curve Shift | Effect on $K_{0.5}$ |
|---|---|---|---|
| Allosteric Activator | R-state (Relaxed) | Leftward | Decreases (Higher Affinity) |
| Allosteric Inhibitor | T-state (Tense) | Rightward | Increases (Lower Affinity) |
4. Physiological Significance: The Metabolic Switch
This kinetic sensitivity allows allosteric enzymes to act as metabolic switches. Small changes in the concentration of a regulatory molecule can lead to massive changes in enzymatic activity, allowing for rapid physiological responses like feedback inhibition.
Examples in Biology
- Phosphofructokinase-1 (PFK-1): The "gatekeeper" of glycolysis. High levels of ATP signal that the cell has enough energy, causing ATP to bind to an allosteric site and inhibit the enzyme. Conversely, high AMP levels signal energy depletion and act as an allosteric activator.
- Aspartate Transcarbamoylase (ATCase): Catalyzes the first step in pyrimidine synthesis. It is inhibited by CTP (the end-product) and activated by ATP (a purine), ensuring a balance between purines and pyrimidines for DNA synthesis.
- Hemoglobin: Although a transport protein rather than a catalyst, it is the classic model for homotropic allostery, where oxygen binding to one subunit increases the oxygen affinity of the others.
Common Misconceptions
| Feature | Competitive Inhibition | Allosteric Inhibition |
|---|---|---|
| Binding Site | Binds directly to the Active Site. | Binds to a separate Allosteric Site. |
| Structure | Inhibitor often resembles the substrate. | Inhibitor usually looks nothing like the substrate. |
| Overcoming Inhibition | Can be overcome by increasing substrate concentration ($[S]$). | Cannot be fully overcome by simply adding more substrate. |
| Kinetics | Increases $K_m$ but $V_{max}$ stays the same. | Changes the shape of the curve (Sigmoidal shift) and often lowers $V_{max}$. |
Note: Not all allosteric enzymes are "multimeric" (having many subunits), but the vast majority are. This quaternary structure is what typically allows for the "cooperative" communication between sites.
Quick Self-Assessment
1. Which of the following is a characteristic of allosteric enzymes but NOT Michaelis-Menten enzymes?
- A) They lower the activation energy of a reaction.
- B) They exhibit a sigmoidal velocity curve.
- C) They possess an active site for substrate binding.
2. If an allosteric inhibitor is added to a reaction, what happens to the $K_{0.5}$ and the curve position?
- A) $K_{0.5}$ decreases; curve shifts to the left.
- B) $K_{0.5}$ increases; curve shifts to the right.
- C) $K_{0.5}$ stays the same; the $V_{max}$ simply drops.
3. In the Concerted (MWC) Model, what state does an activator stabilize?
- A) The T-state (Tense).
- B) The R-state (Relaxed).
- C) Neither; it only changes the substrate concentration.
Check Answers
1. B (Sigmoidal curves represent cooperativity, unique to allosteric enzymes).
2. B (Inhibitors stabilize the T-state, requiring more substrate to reach half-velocity, thus increasing $K_{0.5}$).
3. B (Activators promote the Relaxed state, which has a higher affinity for the substrate).